Disclosures for "Kelch-like Protein-11 Encephalitis Case Report"
-
Dr. Schmoll has nothing to disclose.
-
Dr. Rodenbeck has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals.
-
Dr. Collins has nothing to disclose.